Henoch-Schönlein purpura associated with pidotimod therapy

Clinical and Experimental Rheumatology

Volumn 26, Issue 3 SUPPL. 49, 2008, Pages

  Cantarini, Luca ^a   Brogna, A ^b   Fioravanti, A ^c   Galeazzi, M ^a  

^a Unit of Rheumatology   (Italy)

^b Neonatal Intensive Care Unit   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; PIDOTIMOD;

ABDOMINAL PAIN; ANAMNESIS; ANAPHYLACTOID PURPURA; ANKLE ARTHRITIS; ARTHRITIS; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KNEE ARTHRITIS; LABORATORY TEST; LETTER; PRIORITY JOURNAL; PURPURIC RASH; TONSILLITIS; WALKING DIFFICULTY;

CHILD; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; PURPURA, SCHOENLEIN-HENOCH; PYRROLIDONECARBOXYLIC ACID; THIAZOLIDINES; TONSILLITIS;

EID: 52049105650     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. CALVINO MC, LLORCA J, GARCIA-PORRUA C, FERNANDEZ-INGLESIAS JL, RODRIGUEZ-LEDO P, GONZALEZ-GAY MA: Henoch-Schönlein purpura in children from northwestern Spain: A 20-year epidemiologic and clinical study. Medicine 2001; 80: 279-90.
2. TRAPANI S, MICHELI A, GRISOLIA F et al.: Henoch-Schönlein purpura in childhood: Epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005; 35: 143-53.
3. SAULSBURY FT: Henoch-Schönlein purpura. Curr Opin Rheumatol 2001; 13: 35-40.
4. SAULSBURY FT: Clinical update: Henoch-Schönlein purpura. Lancet 2007; 369: 976-8.
5. COPPI G, MANZARDO S: Experimental immunological screening tests on Pidotimod. Arzneimittelforschung 1994; 44:1411-6.
6. PUGLIESE A, GIRARDELLO R, MARINELLI L, FORNO B, PATTARINO PL, BIGLINO A: Evaluation of Pidotimod effects on some immune parameters. J Chemother 1991; 3: 144.
7. AUTERI A, PASQUI AL, GOITI G et al.: The effect of a new biological response modifier (Pidotimod) on surgery-associated immunodeficiency. Int J Immunotherapy 1993; IX: 95.
8. BENETTI GP, FUGAZZA L, STRAMBA BADIALE M et al.: Ex vivo evaluation of pidotimod activity on cell-mediated immunity. Arzneimittelforschung 1994; 44: 1476-9.
9. + Peyer's patch cells are a novel cell subset which secrete IL-5 in response to IL-2: Implications for their role in IgA production. Eur J Immunol 2004; 34: 1920-9.
10. NARANJO CA, BUSTO U, SELLERS EM et al.: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.